Cell therapy gets a boost as ReNeuron raises $105 million

LONDON (Reuters) - The drug research field of cell therapy received a boost on Friday when British biotech company ReNeuron raised 68.4 million pounds ($106 million) to help fund its work into stroke, blindness and cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news